Commercial Blenderized Tube Feeding Formulas: Recent Evidence Supports Improved Clinical and Health Economic Outcomes



About this Webinar
Learning Objectives:
1. Explain recently published real world evidence on the clinical and health economic outcomes of utilizing commercially blenderized formulas for tube-fed children and adults.
2. Describe at least two examples of how this recent data will change clinical practice.
3. Apply learnings through a case-based approach to identify how and when to utilize commercially blenderized formulas with tube fed patients.